(JHX) James Hardie Industries - Ratings and Ratios
Fiber Cement, Fiber Gypsum, Cement Bonded Boards, Exterior Siding, Interior Linings
JHX EPS (Earnings per Share)
JHX Revenue
Description: JHX James Hardie Industries October 30, 2025
James Hardie Industries plc (NYSE:JHX) manufactures and sells fiber-cement, fiber-gypsum, and cement-bonded boards across the United States, Australia, Europe and New Zealand, organized into three reporting segments: North America Fiber Cement, Asia-Pacific Fiber Cement and Europe Building Products.
The company’s product suite-branded primarily as Hardie™ and supplemented by fermacell and AESTUVER-covers exterior siding, cladding, trim, soffit, and interior linings, with applications ranging from residential housing to industrial fire-protection solutions.
In FY 2023 the firm generated roughly $5.5 billion of revenue and delivered an adjusted EBITDA margin of about 20 %, reflecting strong demand for low-maintenance, fire-resistant building materials, especially in the U.S. residential market, which historically accounts for ~70 % of total sales.
Key macro drivers include U.S. housing starts (up ≈5 % YoY) and tightening building-code requirements that favor fiber-cement products; however, raw-material cost volatility-particularly silica sand and gypsum-adds upside risk to margins.
Assuming the current pace of U.S. construction activity persists, the North America segment could achieve double-digit revenue growth, but a sustained rise in mortgage rates or a slowdown in home-building permits would materially weaken that outlook.
For a data-rich, quantitative assessment of JHX’s valuation and risk profile, see the detailed analysis on ValueRay.
JHX Stock Overview
| Market Cap in USD | 12,227m | 
| Sub-Industry | Construction Materials | 
| IPO / Inception | 2000-01-03 | 
JHX Stock Ratings
| Growth Rating | -37.9% | 
| Fundamental | 57.5% | 
| Dividend Rating | 1.0% | 
| Return 12m vs S&P 500 | -46.9% | 
| Analyst Rating | 4.50 of 5 | 
JHX Dividends
Currently no dividends paidJHX Growth Ratios
| Growth Correlation 3m | -4.4% | 
| Growth Correlation 12m | -81.6% | 
| Growth Correlation 5y | -10.4% | 
| CAGR 5y | -1.44% | 
| CAGR/Max DD 3y (Calmar Ratio) | -0.03 | 
| CAGR/Mean DD 3y (Pain Ratio) | -0.08 | 
| Sharpe Ratio 12m | -0.95 | 
| Alpha | -54.12 | 
| Beta | 0.828 | 
| Volatility | 46.98% | 
| Current Volume | 3104.2k | 
| Average Volume 20d | 4252.5k | 
| Stop Loss | 19.6 (-4.2%) | 
| Signal | -0.31 | 
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (331.3m TTM) > 0 and > 6% of Revenue (6% = 227.1m TTM) | 
| FCFTA 0.06 (>2.0%) and ΔFCFTA -1.66pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) | 
| NWC/Revenue 61.50% (prev 17.56%; Δ 43.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) | 
| CFO/TA 0.12 (>3.0%) and CFO 824.6m > Net Income 331.3m (YES >=105%, WARN >=100%) | 
| Net Debt (2.22b) to EBITDA (784.8m) ratio: 2.83 <= 3.0 (WARN <= 3.5) | 
| Current Ratio 3.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) | 
| Outstanding Shares last Quarter (431.1m) change vs 12m ago -0.78% (target <= -2.0% for YES) | 
| Gross Margin 38.17% (prev 40.56%; Δ -2.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) | 
| Asset Turnover 64.63% (prev 80.64%; Δ -16.01pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) | 
| Interest Coverage Ratio 8.11 (EBITDA TTM 784.8m / Interest Expense TTM 69.3m) >= 6 (WARN >= 3) | 
Altman Z'' 4.21
| (A) 0.34 = (Total Current Assets 3.17b - Total Current Liabilities 843.6m) / Total Assets 6.79b | 
| (B) 0.26 = Retained Earnings (Balance) 1.79b / Total Assets 6.79b | 
| (C) 0.10 = EBIT TTM 561.9m / Avg Total Assets 5.86b | 
| (D) 0.44 = Book Value of Equity 1.98b / Total Liabilities 4.53b | 
| Total Rating: 4.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) | 
ValueRay F-Score (Strict, 0-100) 57.54
| 1. Piotroski 5.0pt = 0.0 | 
| 2. FCF Yield 2.97% = 1.48 | 
| 3. FCF Margin 11.33% = 2.83 | 
| 4. Debt/Equity 1.16 = 1.87 | 
| 5. Debt/Ebitda 2.83 = -1.51 | 
| 6. ROIC - WACC (= 3.26)% = 4.07 | 
| 7. RoE 15.60% = 1.30 | 
| 8. Rev. Trend 6.93% = 0.52 | 
| 9. EPS Trend -60.59% = -3.03 | 
What is the price of JHX shares?
Over the past week, the price has changed by -6.96%, over one month by +0.20%, over three months by -22.33% and over the past year by -35.57%.
Is James Hardie Industries a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JHX is around 17.39 USD . This means that JHX is currently overvalued and has a potential downside of -14.96%.
Is JHX a buy, sell or hold?
- Strong Buy: 1
 - Buy: 1
 - Hold: 0
 - Sell: 0
 - Strong Sell: 0
 
What are the forecasts/targets for the JHX price?
| Issuer | Target | Up/Down from current | 
|---|---|---|
| Wallstreet Target Price | 26.9 | 31.5% | 
| Analysts Target Price | 26.9 | 31.5% | 
| ValueRay Target Price | 19.2 | -5.9% | 
JHX Fundamental Data Overview November 01, 2025
P/E Trailing = 27.4156
P/E Forward = 31.25
P/S = 3.2298
P/B = 5.0621
P/EG = 2.5263
Beta = 0.828
Revenue TTM = 3.79b USD
EBIT TTM = 561.9m USD
EBITDA TTM = 784.8m USD
Long Term Debt = 2.52b USD (from longTermDebt, last quarter)
Short Term Debt = 21.8m USD (from shortTermDebt, last quarter)
Debt = 2.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.22b USD (from netDebt column, last quarter)
Enterprise Value = 14.44b USD (12.23b + Debt 2.61b - CCE 391.6m)
Interest Coverage Ratio = 8.11 (Ebit TTM 561.9m / Interest Expense TTM 69.3m)
FCF Yield = 2.97% (FCF TTM 429.0m / Enterprise Value 14.44b)
FCF Margin = 11.33% (FCF TTM 429.0m / Revenue TTM 3.79b)
Net Margin = 8.75% (Net Income TTM 331.3m / Revenue TTM 3.79b)
Gross Margin = 38.17% ((Revenue TTM 3.79b - Cost of Revenue TTM 2.34b) / Revenue TTM)
Gross Margin QoQ = 37.44% (prev 38.37%)
Tobins Q-Ratio = 2.13 (Enterprise Value 14.44b / Total Assets 6.79b)
Interest Expense / Debt = 1.45% (Interest Expense 37.8m / Debt 2.61b)
Taxrate = 30.21% (27.1m / 89.7m)
NOPAT = 392.1m (EBIT 561.9m * (1 - 30.21%))
Current Ratio = 3.76 (Total Current Assets 3.17b / Total Current Liabilities 843.6m)
Debt / Equity = 1.16 (Debt 2.61b / totalStockholderEquity, last quarter 2.26b)
Debt / EBITDA = 2.83 (Net Debt 2.22b / EBITDA 784.8m)
Debt / FCF = 5.17 (Net Debt 2.22b / FCF TTM 429.0m)
Total Stockholder Equity = 2.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.88% (Net Income 331.3m / Total Assets 6.79b)
RoE = 15.60% (Net Income TTM 331.3m / Total Stockholder Equity 2.12b)
RoCE = 12.09% (EBIT 561.9m / Capital Employed (Equity 2.12b + L.T.Debt 2.52b))
RoIC = 10.91% (NOPAT 392.1m / Invested Capital 3.59b)
WACC = 7.65% (E(12.23b)/V(14.84b) * Re(9.07%) + D(2.61b)/V(14.84b) * Rd(1.45%) * (1-Tc(0.30)))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.82%
[DCF Debug] Terminal Value 74.05% ; FCFE base≈414.8m ; Y1≈401.0m ; Y5≈397.5m
Fair Price DCF = 10.19 (DCF Value 5.90b / Shares Outstanding 579.2m; 5y FCF grow -4.56% → 3.0% )
EPS Correlation: -60.59 | EPS CAGR: -57.34% | SUE: -2.02 | # QB: 0
Revenue Correlation: 6.93 | Revenue CAGR: -3.68% | SUE: -0.11 | # QB: 0
Additional Sources for JHX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle